The estimated Net Worth of Ratan S Borkar is at least 7.64 百万$ dollars as of 18 May 2020. Mr. Borkar owns over 28,312 units of QuidelOrtho stock worth over 23,501$ and over the last 7 years he sold QDEL stock worth over 6,244,901$. In addition, he makes 1,371,140$ as Senior Vice President - International Commercial Operations at QuidelOrtho.
Sign up
Mr. Borkar QDEL stock SEC Form 4 insiders trading
Ratan has made over 9 trades of the QuidelOrtho stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 28,312 units of QDEL stock worth 5,459,120$ on 18 May 2020.
The largest trade he's ever made was exercising 29,880 units of QuidelOrtho stock on 3 January 2018 worth over 575,190$. On average, Ratan trades about 6,169 units every 35 days since 2017. As of 18 May 2020 he still owns at least 524 units of QuidelOrtho stock.
You can see the complete history of Mr. Borkar stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ratan Borkar biography
Ratan S. Borkar is Senior Vice President - International Commercial Operations of the Company. He joined Quidel in May 2009 as Vice President, Business Development. In February 2012, Mr. Borkar moved into the role of VP, International Commercial Operations. Prior to Quidel, Mr. Borkar had a career in Investment Banking, where he most recently worked at J.P. Morgan as Vice President in the Healthcare Investment Banking Group, advising companies in the diagnostics, life sciences and clinical research areas. Mr. Borkar started his career at KPMG and is a Chartered Accountant. Mr. Borkar has an MBA from the University of Michigan’s Ross School of Business, where he was an Alan Gelband Scholar. Mr. Borkar received his Bachelor of Commerce from the University of Mumbai.
What is the salary of Ratan Borkar?
As the Senior Vice President - International Commercial Operations of QuidelOrtho, the total compensation of Ratan Borkar at QuidelOrtho is 1,371,140$. There are 5 executives at QuidelOrtho getting paid more, with Douglas Bryant having the highest compensation of 4,168,770$.
How old is Ratan Borkar?
Ratan Borkar is 46, he's been the Senior Vice President - International Commercial Operations of QuidelOrtho since 2017. There are 28 older and no younger executives at QuidelOrtho. The oldest executive at QuidelOrtho Corporation is Mary Polan, 76, who is the Independent Director.
Insiders trading at QuidelOrtho
Over the last 21 years, insiders at QuidelOrtho have traded over 509,235,797$ worth of QuidelOrtho stock and bought 304,015 units worth 10,385,234$ . The most active insiders traders include Jack W Schuler、Matthew Strobeck、Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of 1,246,606$. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth 3,078,785$.
What does QuidelOrtho do?
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
What does QuidelOrtho's logo look like?
Complete history of Mr. Borkar stock trades at QuidelOrtho
QuidelOrtho executives and stock owners
QuidelOrtho executives and other stock owners filed with the SEC include:
-
Douglas Bryant,
President, Chief Executive Officer, Director -
Douglas C. Bryant,
Pres, CEO & Director -
Randall Steward,
Chief Financial Officer -
Michael Abney,
Senior Vice President - Distribution -
Robert Bujarski,
Chief Operating Officer -
Ratan Borkar,
Senior Vice President - International Commercial Operations -
Werner Kroll,
Senior Vice President - R&D -
Edward Russell,
Senior Vice President - Business Development -
Robert J. Bujarski,
Chief Operating Officer -
Randall J. Steward,
Chief Financial Officer -
Dr. Werner Kroll,
Sr. VP of R&D -
Ratan S. Borkar,
Sr. VP of International Commercial Operations -
Robert J. Bujarski J.D.,
Pres & COO -
Kenneth Buechler,
Independent Chairman of the Board -
Edward Michael,
Independent Director -
Ken Widder,
Independent Director -
Charles Slacik,
Independent Director -
Matthew Strobeck,
Independent Director -
Mary Polan,
Independent Director -
Kathy Ordonez,
Independent Director -
Ruben Argueta,
Director - Investor Relations -
Ann Rhoads,
Director -
Karen Gibson,
Senior Vice President, Information Systems and Business Transformation -
Dr. Chockalingam Palaniappan Ph.D.,
Chief Innovation Officer -
Patrick E. Klein,
Chief Admin. Officer -
Louise Brandy,
Chief Information Officer -
Rhys de Callier,
VP of Strategy & Portfolio Management -
Dr. Johannes Kehle,
Pres of AnDiaTec Division -
Phillip S. Askim,
VP, Associate Gen. Counsel & Sec. -
Michael S. Iskra,
Chief Commercial Officer -
Joseph M. Busky CPA,
Chief Financial Officer -
Karen C. Gibson,
Sr. VP of Digital Health Bus. Unit -
Edward Keith Russell,
Sr. VP of Bus. Devel. -
Michael Donald Abney Jr.,
Sr. VP of North American Sales & Distribution -
Michelle A. Hodges,
Sr. VP & Gen. Counsel -
Group Inc.Carlyle Holdings ...,
-
Thomas D Brown,
Director -
Rodney F Dammeyer,
Director -
John Tamerius,
Sr. VP - Clinical/Reg Affairs -
Patrick Klein,
Chief Administrative Officer -
Louise Brandy,
SVP, Chief Information Officer -
Tamara A. Ranalli,
SVP, Molecular Bus. Unit -
Mark W Smits,
SVP-Commercial Operations -
Mark Pulido,
Director -
John Matthew Radak,
Chief Financial Officer -
Timothy Todd Stenzel,
Chief Science Officer -
Scot M Mc Leod,
Sr. VP - Operations -
Caren L Mason,
President and CEO -
Jack W Schuler,
Director -
Thomas James Foley,
Chief Technical Officer -
David R. Scholl,
Senior Vice President -
Richard C Iii Tarbox,
Sr. VP - Corporate Development -
Matthew T Heindel,
Sr. VP - Global Sales & Mrktg -
Douglas S Harrington,
Director -
Faye Wattleton,
Director -
Mark Paiz,
Senior Vice President -
Thomas A Glaze,
Director -
Paul E Landers,
Sr. V.P., CFO and Secretary -
S Wayne Kay,
President & CEO -
William J. Ferenczy,
SVP, Cardio/Metabolic Unit -
Michael S. Iskra,
EVP & CCO -
Christopher M Smith,
Director -
Joseph D Jr. Wilkins,
-
Evelyn S Dilsaver,
-
Joseph M Busky,
Chief Financial Officer -
James Prutow,
-
Michelle A. Hodges,
SVP, General Counsel